{"id":"W2120820093","doi":"10.1093/neuonc/not035","title":"Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Alberta Innovates; Killam Trusts; Terry Fox Foundation; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; In vivo; Neurosphere; Temozolomide; Biology; Virotherapy; Cancer research; Stem cell; In vitro; Population; Brain tumor; Glioma; Immunology; Medicine; Virus; Pathology; Cell biology; Tumor cells","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003310873,0.0001503714,0.000237056,0.00009951763,0.00009963456,0.00002057827,0.0001443404,0.0001424824,0.00006580329],"category_scores_gemma":[0.0002410572,0.0001544757,0.0000548226,0.0001231564,0.0001500739,0.000009219291,0.0001354097,0.0001532331,0.000009093972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003648903,"about_ca_system_score_gemma":0.0001649752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001431231,"about_ca_topic_score_gemma":0.00008442239,"domain_scores_codex":[0.9984937,0.0004283327,0.0003027866,0.0003370846,0.0001339331,0.0003041335],"domain_scores_gemma":[0.9991365,0.0002059712,0.0001954842,0.0002334167,0.0001377356,0.00009090102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000235932,0.00009922197,0.0008393925,0.0000238319,0.00002018174,0.00001013892,0.0001276958,0.00005542222,0.9843815,0.00001127468,0.000374617,0.01382081],"study_design_scores_gemma":[0.001339768,0.004646674,0.0004395757,0.000007774419,0.00001119709,0.00004984883,0.0001370067,0.002831857,0.9891177,0.0000812896,0.001206411,0.0001309361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980042,0.0002000614,0.0001165457,0.0004060736,0.00008760949,0.0003732074,0.000009349879,0.00001231556,0.0007906393],"genre_scores_gemma":[0.997954,0.00004362185,0.0007165286,0.001070587,0.0001021791,0.00003121541,0.00001694967,0.00003353376,0.00003138491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01368988,"threshold_uncertainty_score":0.6299335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02383856577493879,"score_gpt":0.3136653750383318,"score_spread":0.289826809263393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}